At SciBase, we are committed to empowering healthcare professionals by developing science-based, innovative solutions to address unmet needs for skin disorders and enable early detection of skin cancers. We develop unique, point-of-care platforms that combine artificial intelligence with our advanced EIS technology. By transforming the management of skin disorders, our solutions improve diagnostic accuracy, enable disease monitoring, and detection of skin disease to empower early intervention to facilitate predictive care- we deliver solutions that reduce healthcare costs, diminish unnecessary patient suffering, and ultimately help clinicians improve and save lives.
The strategy currently focuses on three areas:
1. Focus on the US Market
- Continued expansion in the US through broader reimbursement and NMSC.
2. Focus on EU markets
- Sales growth in Germany
- Expand in DACH
3. Barrier development and launch
- First Limited launch in Germany.